10% Off
Aldorin50 mg
Eskayef Bangladesh Ltd.
৳99.00
Add to cart
Generic medicine
Epalrestat: Brands, Price & Uses in Bangladesh
Epalrestat is an aldose reductase inhibitor used as an adjunctive treatment for diabetic peripheral neuropathy (numbness, tingling, pain and more.
About Epalrestat
Indications of Epalrestat
Epalrestat is an aldose reductase inhibitor used as an adjunctive treatment for diabetic peripheral neuropathy (numbness, tingling, pain, and reduced sensation in the extremities caused by long-standing diabetes mellitus). It is used alongside, not as a substitute for, good glycemic control achieved with diet, exercise, and antidiabetic medication.
- Established use: Improvement of subjective symptoms of diabetic peripheral neuropathy (spontaneous pain, numbness, and abnormal sensation in the limbs) and objective findings such as reduced motor and sensory nerve conduction velocity and vibration sense abnormalities.
- Adjunctive use: Epalrestat must be used in addition to, not instead of, standard glycemic control measures; it is not a treatment for diabetes itself.
- Regional approval note: Epalrestat is approved and marketed in Japan, India, China, and Bangladesh for this indication, but it does not have marketing approval in the United States, the United Kingdom, or the European Union, so it is not listed in FDA or EMA drug labels.
Dosage & Administration of Epalrestat
Adult Dose
| Indication | Dose | Frequency | Timing |
|---|---|---|---|
| Diabetic peripheral neuropathy | 50 mg | Three times daily | Before each meal |
Epalrestat should be taken consistently before meals, as food intake can reduce its absorption. Response to therapy, particularly improvement in neuropathic symptoms and nerve conduction parameters, should be assessed periodically, and continued benefit should be re-evaluated by the prescribing physician after a few months of use.
Pediatric Dose
Epalrestat is not indicated for use in children; safety and efficacy in the pediatric population have not been established, as diabetic peripheral neuropathy requiring this therapy is a condition of long-standing adult diabetes.
Renal/Hepatic Adjustment
Epalrestat should be used with caution and under close medical supervision in patients with hepatic impairment because of the risk of hepatotoxicity (see Precautions and Warnings). It is contraindicated in severe hepatic impairment. Specific dose adjustment guidance for renal impairment has not been well established; such patients should be monitored closely if Epalrestat is used.
Side Effects of Epalrestat
Most patients tolerate Epalrestat well. Reported side effects include:
- Common: Gastrointestinal disturbances such as nausea, vomiting, and abdominal discomfort.
- Notable/expected but harmless: Reddish-brown discoloration of urine. This is a harmless pigment-related effect of the drug and does not indicate kidney or blood problems; patients should be counseled about this in advance so it is not mistaken for a sign of a serious complication such as hematuria.
- Uncommon: Elevated liver enzymes (transaminases), which is usually reversible on stopping the drug; rare cases of clinically significant hepatotoxicity have been reported (see Precautions and Warnings).
- Rare: Skin rash or hypersensitivity reactions.
Patients should report persistent gastrointestinal symptoms, yellowing of the skin/eyes, unusual fatigue, or skin reactions to their physician promptly.
Contraindications of Epalrestat
Epalrestat is contraindicated in patients with:
- Known hypersensitivity to Epalrestat or any component of the formulation.
- Severe hepatic impairment.
Frequently Asked Questions about Epalrestat
What is Epalrestat used for?
Epalrestat is used as an adjunctive treatment for diabetic peripheral neuropathy, helping to reduce symptoms such as numbness, tingling, and pain in the limbs caused by long-standing diabetes. It is used together with, not instead of, standard blood sugar control.
Why does my urine turn reddish-brown while taking Epalrestat?
A reddish-brown discoloration of urine is a known and harmless effect of Epalrestat caused by a pigment related to the drug. It does not indicate kidney damage or bleeding, but you should still mention it to your doctor at your next visit so it can be confirmed as an expected effect.
Can Epalrestat replace my diabetes medicine?
No. Epalrestat is an adjunct therapy for nerve complications of diabetes and does not control blood sugar. You must continue your prescribed antidiabetic medications, diet, and exercise plan alongside Epalrestat.
Is Epalrestat safe for the liver?
Epalrestat can rarely cause elevated liver enzymes or, in rare cases, more serious liver injury. Your doctor may order periodic liver function tests during treatment, and Epalrestat should not be used at all in people with severe hepatic impairment. Report symptoms like yellowing of the eyes/skin, dark urine, or persistent nausea immediately.
Can I take Epalrestat during pregnancy or while breastfeeding?
The safety of Epalrestat during pregnancy and breastfeeding has not been well established. It should only be used in these situations if your physician determines that the potential benefit outweighs the potential risk, so always consult your doctor first.
When should I take Epalrestat for the best effect?
Epalrestat is usually taken as 50 mg three times daily, before each meal, since food can reduce its absorption. Take it consistently at the same times each day and continue for the duration recommended by your physician.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.